You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 19, May 21, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Hypertension
 •Alert me on articles by topic

JNC 7—It's More Than High Blood Pressure

Thomas E. Kottke, MD, MSPH; Robert J. Stroebel, MD; Rebecca S. Hoffman, BA

JAMA. 2003;289:2573-2575.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The World Health Organization has estimated that high blood pressure causes 1 in every 8 deaths worldwide, making hypertension the third leading killer in the world.1 The JNC 7 report,2 published in this issue of THE JOURNAL, summarizes how the burden of hypertension can be decreased. Among the messages emphasized is that systolic blood pressure control should be the focus of treatment. Cardiovascular risk from systolic hypertension begins at 115 mm Hg and risk from diastolic hypertension begins at 75 mm Hg. Individuals who are normotensive at 55 years have a 90% likelihood of developing high blood pressure during the next 25 years, and lowering blood pressure toward the new goal level of 120/80 mm Hg will decrease heart attacks, heart failure, stroke, kidney disease, and will save lives.

In addition, the JNC 7 report reenforces several . . . [Full Text of this Article]

Author Affiliations: CardioVision 2020, Olmsted County, Minn (Dr Kottke); Division of Community Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn (Dr Stroebel); and Rebecca Hoffman Inc, San Francisco, Calif (Ms Hoffman).


RELATED ARTICLES

Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents: A Network Meta-analysis
Bruce M. Psaty, Thomas Lumley, Curt D. Furberg, Gina Schellenbaum, Marco Pahor, Michael H. Alderman, and Noel S. Weiss
JAMA. 2003;289(19):2534-2544.
ABSTRACT | FULL TEXT  

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
Aram V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green, Joseph L. Izzo, Jr, Daniel W. Jones, Barry J. Materson, Suzanne Oparil, Jackson T. Wright, Jr, and Edward J. Roccella
JAMA. 2003;289(19):2560-2571.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Orthostatic hypotension: framework of the syndrome
Naschitz and Rosner
Postgrad. Med. J. 2007;83:568-574.
ABSTRACT | FULL TEXT  

Effects of Prehypertension on Admissions and Deaths: A Simulation
Russell et al.
Arch Intern Med 2004;164:2119-2124.
ABSTRACT | FULL TEXT  

New Hypertension Guidelines: JNC 7
JWatch Gastroenterology 2003;2003:9-9.
FULL TEXT  

Guidelines: Hypertension Prevention and Management -- JNC 7
Journal Watch Cardiology 2003;2003:1-1.
FULL TEXT  

New Hypertension Guidelines: JNC 7
JWatch General 2003;2003:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.